Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional)

The purpose of this funding opportunity is to develop technologies to improve the delivery of pharmacological, gene editing, or other cargoes for HIV and SUD mechanistic research.

Funding Organization

National Institutes of Health

Funding Category

HIV/AIDS

Support Types

Officers and Trustees Discretionary Grants

Locations

National

Eligible Organizations

City Agencies

Colleges/Universities

Commercial Organizations

Community Based Organizations

County Agencies

IRS 501 (c)(3) Organizations

Nonprofit Organizations

Religious Organizations

State Agencies

Tribal Organizations

Number of Awards Given

Four to six awards.

Maximum Amount:

2000000.00

Website URL:

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-010.html

Application Due Date

10/25/21

Project Start Date

7/1/22

Application Contact

Cheryl

Nathaniel

Grants Management Specialist

301-827-6703

cnathanic@nih.gov

Technical Contact

Jonathan D.

Pollock, Ph.D

Branch Chief, Genetics, Epigenetics, and Developmental Neuroscience

jpollock@mail.nih.gov

301-435-1309

Subjects

Audiences

Fund Number:

354694

Fund ID:

RFA-DA-22-010

Last modified:

3/2/21

National Prevention Information NetworkBETA

Connecting public health professionals with trusted information and each other.

Introducing NPIN’s Social Community

Introducing NPIN’s Social Community

Introducing NPIN’s Social Community

Introducing NPIN’s Social Community